Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ADMS

Adamas Pharmaceuticals (ADMS)

Adamas Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ADMS
DateTimeSourceHeadlineSymbolCompany
05/10/20214:03PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ADMSAdamas Pharmaceuticals Inc
05/10/20214:02PMBusiness WireAdamas Reports First Quarter 2021 Financial ResultsNASDAQ:ADMSAdamas Pharmaceuticals Inc
05/07/20214:05PMBusiness WireAdamas Announces New Employment Inducement GrantNASDAQ:ADMSAdamas Pharmaceuticals Inc
04/29/20214:04PMBusiness WireAdamas to Present at Upcoming BofA ConferenceNASDAQ:ADMSAdamas Pharmaceuticals Inc
04/27/20219:15AMBusiness WireAdamas Launches “Picture More Time” Campaign to Raise Awareness & Understanding of the Impact of OFF Time & Dyskinesia fo...NASDAQ:ADMSAdamas Pharmaceuticals Inc
04/26/20214:04PMBusiness WireAdamas to Announce First Quarter Financial Results and Host Conference Call on May 10, 2021NASDAQ:ADMSAdamas Pharmaceuticals Inc
04/19/20214:04PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
04/19/20214:03PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
04/19/20219:15AMBusiness WireSurvey data detailing impact of OFF time & dyskinesia in people affected by Parkinson’s disease presented at American Acade...NASDAQ:ADMSAdamas Pharmaceuticals Inc
04/15/20219:15AMBusiness WireAdamas Announces Two Presentations for the American Academy of Neurology 73rd Annual MeetingNASDAQ:ADMSAdamas Pharmaceuticals Inc
04/07/20215:19PMBusiness WireAdamas to Present at Upcoming Needham ConferenceNASDAQ:ADMSAdamas Pharmaceuticals Inc
03/29/20219:15AMBusiness WireAdamas publishes new data analyses demonstrating GOCOVRI treatment more than doubled ON time without dyskinesia in patients w...NASDAQ:ADMSAdamas Pharmaceuticals Inc
03/23/20216:03PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
03/10/20219:48AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ADMSAdamas Pharmaceuticals Inc
03/05/20214:02PMBusiness WireAdamas Announces New Employment Inducement GrantNASDAQ:ADMSAdamas Pharmaceuticals Inc
03/03/20215:02PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
03/02/20216:01AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ADMSAdamas Pharmaceuticals Inc
03/01/20214:04PMBusiness WireAdamas Pharmaceuticals Announces Closing of Public Offering of Common Stock & Full Exercise of Underwriters’ Option to Purc...NASDAQ:ADMSAdamas Pharmaceuticals Inc
02/25/20214:16PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMSAdamas Pharmaceuticals Inc
02/25/20214:01PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ADMSAdamas Pharmaceuticals Inc
02/24/20219:16PMBusiness WireAdamas Pharmaceuticals Announces Pricing of Follow-on Public OfferingNASDAQ:ADMSAdamas Pharmaceuticals Inc
02/24/20214:08PMBusiness WireAdamas Pharmaceuticals Announces Launch of Follow-on Public OfferingNASDAQ:ADMSAdamas Pharmaceuticals Inc
02/24/20214:06PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ADMSAdamas Pharmaceuticals Inc
02/23/20214:16PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ADMSAdamas Pharmaceuticals Inc
02/23/20214:03PMBusiness WireAdamas Reports Fourth Quarter and Full Year 2020 Financial ResultsNASDAQ:ADMSAdamas Pharmaceuticals Inc
02/23/20214:02PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:ADMSAdamas Pharmaceuticals Inc
02/22/20217:18AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ADMSAdamas Pharmaceuticals Inc
02/17/20214:06PMBusiness WireAdamas to Present at Upcoming Healthcare ConferencesNASDAQ:ADMSAdamas Pharmaceuticals Inc
02/12/20216:19PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
02/12/20215:20PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ADMS